These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27489082)

  • 1. Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.
    Zhao S; Xia M; Tang J; Yan Y
    BJU Int; 2017 Oct; 120(4):482-489. PubMed ID: 27489082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of metabolic syndrome and its components with serum prostate-specific antigen levels.
    Gao X; Bao T; Yang H; Lei Y; Jiang X; Huang Y; Huang W; Tang H
    Eur J Cancer Prev; 2020 Jan; 29(1):36-41. PubMed ID: 30913093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The illusion of prostate-specific antigen decline in patients with metabolic syndrome and insulin resistance.
    Choi HC; Park JH; Cho BL; Son KY; Yoo YJ; Kwon HT
    BJU Int; 2011 Dec; 108(11):1756-61. PubMed ID: 21507191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
    Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
    JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of pathogenic factors of metabolic syndrome on serum prostate-specific antigen levels: a pilot study.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    BMC Urol; 2019 Nov; 19(1):119. PubMed ID: 31752806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.
    Catalona WJ; Smith DS; Wolfert RL; Wang TJ; Rittenhouse HG; Ratliff TL; Nadler RB
    JAMA; 1995 Oct; 274(15):1214-20. PubMed ID: 7563511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.
    Sourbeer KN; Howard LE; Andriole GL; Moreira DM; Castro-Santamaria R; Freedland SJ; Vidal AC
    BJU Int; 2015 May; 115(5):736-43. PubMed ID: 24931061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.
    Zhang J; Ma M; Nan X; Sheng B
    Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
    Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E
    Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.
    Yin Z; Yang JR; Rao JM; Song W; Zhou KQ
    Asian J Androl; 2015; 17(5):826-30. PubMed ID: 25677137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients.
    Zou C; Gong D; Fang N; Fan Y
    World J Urol; 2016 Feb; 34(2):281-9. PubMed ID: 26119349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism.
    Bosch JL; Hop WC; Bangma CH; Kirkels WJ; Schröder FH
    Prostate; 1995 Nov; 27(5):241-9. PubMed ID: 7479391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of Metabolic Components with Prostate Volume in Middle-Aged Men Receiving Health Check-Up.
    Yang TK; Woo P; Yang HJ; Chang HC; Hsieh JT; Huang KH
    PLoS One; 2016; 11(1):e0145050. PubMed ID: 26731481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of metabolic syndrome and its components with serum prostate-specific antigen levels in a Korean-screened population.
    Jeong IG; Hwang SS; Kim HK; Ahn H; Kim CS
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):371-80. PubMed ID: 20086117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
    Kjaer TN; Ornstrup MJ; Poulsen MM; Jørgensen JO; Hougaard DM; Cohen AS; Neghabat S; Richelsen B; Pedersen SB
    Prostate; 2015 Sep; 75(12):1255-63. PubMed ID: 25939591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and screening PSA levels among men undergoing an annual physical exam.
    Rundle A; Neugut AI
    Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary problems and prostate-specific antigen in a Norwegian normal population].
    Eide IA; Angelsen A; Øverland GB; Vada K; Vatten L
    Tidsskr Nor Laegeforen; 2001 Feb; 121(5):553-6. PubMed ID: 11301608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.